Dose Escalation Study to Determine the Pharmacokinetics of Atazanavir Administered With RIfampicin to HIV Positive Adults on sEcond-line ART Regimen With Suppressed HIV-1 Viral Load
Conditions: HIV/AIDS; Tuberculosis Intervention: Drug: Dose escalation Sponsors: University of Liverpool; European and Developing Countries Clinical Trials Partnership (EDCTP); Joint Clinical Research Centre, Kampala, Uganda; University of Cape Town, Cape Town, South Africa; Infectious Diseases Institute, Makerere University College of Health Scienc es, Kampala, Uganda; University of Turin, Turin, Italy Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: African Health | Clinical Trials | HIV AIDS | Infectious Diseases | Italy Health | Partnerships | Research | Study | Tuberculosis | Uganda Health